Pharmaids Pharmaceuticals Share Price
Start SIP in Pharmaids Pharmaceuticals
Start SIPPharmaids Pharmaceuticals Performance
Day Range
- Low 0
- High 0
52 Week Range
- Low 0
- High 0
- Open Price0
- Previous Close0
- Volume
Pharmaids Pharmaceuticals Investment Rating
-
Master Rating:
-
Pharmaids Pharms. has an operating revenue of Rs. 10.80 Cr. on a trailing 12-month basis. Pre-tax margin of -103% needs improvement, ROE of -11% is poor and needs improvement. The company has a reasonable debt to equity of 5%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 7 which is a POOR score indicating inconsistency in earnings, a RS Rating of 11 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 54 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses Qtr Cr | 2 | 2 | 1 | 1 | 2 | 9 |
| Operating Profit Qtr Cr | -2 | -2 | -1 | -1 | -2 | -9 |
| Depreciation Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 0 | 0 | -1 | -1 | 0 | -2 |
| Net Profit Qtr Cr | -2 | -2 | -2 | -1 | -1 | -6 |
Pharmaids Pharmaceuticals Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- ₹41.40
- 50 Day
- ₹43.81
- 100 Day
- ₹46.78
- 200 Day
- ₹47.17
- 20 Day
- ₹41.43
- 50 Day
- ₹43.78
- 100 Day
- ₹48.60
- 200 Day
- ₹51.69
Pharmaids Pharmaceuticals Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 41.94 |
| Second Resistance | 44.33 |
| Third Resistance | 46.20 |
| RSI | 41.77 |
| MFI | 54.86 |
| MACD Single Line | -1.11 |
| MACD | -0.87 |
| Support | |
|---|---|
| First Support | 37.68 |
| Second Support | 35.81 |
| Third Supoort | 33.42 |
Pharmaids Pharmaceuticals Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 16,048 | 1,370,178 | 85.38 |
| Week | 30,234 | 2,523,044 | 83.45 |
| 1 Month | 20,135 | 1,704,644 | 84.66 |
| 6 Month | 11,731 | 1,057,531 | 90.15 |
Pharmaids Pharmaceuticals Result Highlights
Pharmaids Pharmaceuticals Synopsis
BSE-Medical-Diversified
Pharmaids Pharma belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 0.03 Cr. and Equity Capital is Rs. 35.27 Cr. for the Year ended 31/03/2024. Pharmaids Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 01/03/1989 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L52520KA1989PLC173979 and registration number is 173979.| Market Cap | 147 |
| Sales | 0 |
| Shares in Float | 3.32 |
| No of funds | |
| Yield |
| Book Value | 2.08 |
| U/D Vol ratio | 0.8 |
| LTDebt / Equity | 18 |
| Alpha | 0.06 |
| Beta | 0.17 |
Pharmaids Pharmaceuticals Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 |
|---|---|---|---|
| Promoters | 5.56% | 5.64% | 9.25% |
| Individual Investors | 41.14% | 41.06% | 60.78% |
| Others | 53.3% | 53.3% | 29.97% |
Pharmaids Pharmaceuticals Management
| Name | Designation |
|---|---|
| Dr. Shankarappa Nagaraja Vinaya Babu | Chairman, Non Ind & Non Exe Director |
| Mr. Venu Madhava Kaparthy | Executive Director |
| Ms. Mini Manikantan | Executive Director |
| Mr. Shreedhara Shetty | Non Exe.Non Ind.Director |
| Mr. Methuku Nagesh | Independent Director |
| Mr. P N Vijay | Independent Director |
| Mr. Mopperthy Sudheer | Independent Director |
Pharmaids Pharmaceuticals Forecast
Price Estimates
Pharmaids Pharmaceuticals Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-05-28 | Audited Results | |
| 2024-02-12 | Quarterly Results | |
| 2024-01-06 | Preferential issue of shares | |
| 2023-11-11 | Quarterly Results | |
| 2023-08-04 | Quarterly Results |
Pharmaids Pharmaceuticals FAQs
What is Share Price of Pharmaids Pharmaceuticals ?
Pharmaids Pharmaceuticals share price is ₹39 As on 19 September, 2024 | 20:45
What is the Market Cap of Pharmaids Pharmaceuticals ?
The Market Cap of Pharmaids Pharmaceuticals is ₹141 Cr As on 19 September, 2024 | 20:45
What is the P/E ratio of Pharmaids Pharmaceuticals ?
The P/E ratio of Pharmaids Pharmaceuticals is -13.6 As on 19 September, 2024 | 20:45
What is the PB ratio of Pharmaids Pharmaceuticals ?
The PB ratio of Pharmaids Pharmaceuticals is 2 As on 19 September, 2024 | 20:45